We are now Axiom Biosciences. New name, same mission: regenerative cell therapies for severe brain injury, starting with newborns who've had no options, now paired with AI-driven drug design. https://t.co/ADeXyuqfm0
Financing Led by Partners Investment, with World-Class Group of Existing and New Investors. Pipeline of Multiple Programs and Proprietary Cargocyte™ Drug Delivery Platform to Fuel Continued Portfolio Development: https://t.co/FzDDZGp4lV #medicine@CytonusTx
What an impactful event this past week hosted by @ACGTFoundation The world’s brightest minds in one room talking about strategies to cure #Cancer. Two amazing scientist Drs. Gomez-Manzano and Fueyo from @MDAndersonNews I’m privileged to work with and call my friends.
We’re happy to welcome Dr Michael Houston to our SAB. Arguably no one knows more about mRNA than Dr Houston! #NextGen#Cargocyte#mrna https://t.co/ZdcBbYwkWf
When you’re able to talk science and investing with two brilliant VCs you can’t help but to smile ear to ear. If you’re in #NYC and attending #BioFuture2022 make sure to catch @OlgaDanilchanka and Sanjay Mistry PhD panel discussion tomorrow. #fingeronthepulse#biotech
Our CSO Prof. Richard Klemke representing our revolutionary platforms at #CGMesa22 @alliancerm in our home town of #SanDiego where innovation thrives.
VCs who rejected us now circling back about investing because they heard about us getting interest from other VCs - so pathetic.
Where is your self respect? Where is your "contrarian thinking"? Where can I send my bank account information? How fast can you wire?